关于知识产权 知识产权培训 树立尊重知识产权的风尚 知识产权外联 部门知识产权 知识产权和热点议题 特定领域知识产权 专利和技术信息 商标信息 工业品外观设计信息 地理标志信息 植物品种信息(UPOV) 知识产权法律、条约和判决 知识产权资源 知识产权报告 专利保护 商标保护 工业品外观设计保护 地理标志保护 植物品种保护(UPOV) 知识产权争议解决 知识产权局业务解决方案 知识产权服务缴费 谈判与决策 发展合作 创新支持 公私伙伴关系 人工智能工具和服务 组织简介 与产权组织合作 问责制 专利 商标 工业品外观设计 地理标志 版权 商业秘密 WIPO学院 讲习班和研讨会 知识产权执法 WIPO ALERT 宣传 世界知识产权日 WIPO杂志 案例研究和成功故事 知识产权新闻 产权组织奖 企业 高校 土著人民 司法机构 遗传资源、传统知识和传统文化表现形式 经济学 金融 无形资产 性别平等 全球卫生 气候变化 竞争政策 可持续发展目标 前沿技术 移动应用 体育 旅游 PATENTSCOPE 专利分析 国际专利分类 ARDI - 研究促进创新 ASPI - 专业化专利信息 全球品牌数据库 马德里监视器 Article 6ter Express数据库 尼斯分类 维也纳分类 全球外观设计数据库 国际外观设计公报 Hague Express数据库 洛迦诺分类 Lisbon Express数据库 全球品牌数据库地理标志信息 PLUTO植物品种数据库 GENIE数据库 产权组织管理的条约 WIPO Lex - 知识产权法律、条约和判决 产权组织标准 知识产权统计 WIPO Pearl(术语) 产权组织出版物 国家知识产权概况 产权组织知识中心 产权组织技术趋势 全球创新指数 世界知识产权报告 PCT - 国际专利体系 ePCT 布达佩斯 - 国际微生物保藏体系 马德里 - 国际商标体系 eMadrid 第六条之三(徽章、旗帜、国徽) 海牙 - 国际外观设计体系 eHague 里斯本 - 国际地理标志体系 eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange 调解 仲裁 专家裁决 域名争议 检索和审查集中式接入(CASE) 数字查询服务(DAS) WIPO Pay 产权组织往来账户 产权组织各大会 常设委员会 会议日历 WIPO Webcast 产权组织正式文件 发展议程 技术援助 知识产权培训机构 COVID-19支持 国家知识产权战略 政策和立法咨询 合作枢纽 技术与创新支持中心(TISC) 技术转移 发明人援助计划(IAP) WIPO GREEN 产权组织的PAT-INFORMED 无障碍图书联合会 产权组织服务创作者 WIPO Translate 语音转文字 分类助手 成员国 观察员 总干事 部门活动 驻外办事处 职位空缺 采购 成果和预算 财务报告 监督
Arabic English Spanish French Russian Chinese
法律 条约 判决 按管辖区浏览

欧洲共同体(为向有公共健康危机的国家出口医疗制品涉及专利强制许可)实施细则2008(2008年第 S.I. 408 号), 爱尔兰

返回
WIPO Lex中的最新版本
详情 详情 版本年份 2008 日期 生效: 2008年10月10日 发布: 2008年10月10日 文本类型 实施规则/实施细则 主题 专利(发明) 主题(二级) 知识产权监管机构 The European Communities (Compulsory Licensing of Patents Relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Problems) Regulations 2008 were issued by Minister for Enterprise, Trade and Employment pursuant to section 3 of the European Communities Act 1972 (No. 27 of 1972) to give effect to Council Regulation (EC) No. 816/2006 of the European Parliament and of the Council of 17 May 2006.

可用资料

主要文本 相关文本
主要文本 主要文本 英语 European Communities (Compulsory Licensing of Patents Relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Problems) Regulations 2008 (S.I. No. 408/2008)        
 European Communities (Compulsory Licensing of Patents Relating to the manufacture of pharmaceutical products for export to countries with public health problems) Regulations 2008

STATUTORY INSTRUMENTS

S.I. No. 408 of 2008

————————

EUROPEAN COMMUNITIES (COMPULSORY LICENSING OF PATENTS RELATING TO THE MANUFACTURE OF

PHARMACEUTICAL PRODUCTS FOR EXPORT TO COUNTRIES WITH PUBLIC HEALTH PROBLEMS) REGULATIONS 2008

(Prn. A8/1651)

2 [408]

S.I. No. 408 of 2008

EUROPEAN COMMUNITIES (COMPULSORY LICENSING OF PATENTS RELATING TO THE MANUFACTURE OF

PHARMACEUTICAL PRODUCTS FOR EXPORT TO COUNTRIES WITH PUBLIC HEALTH PROBLEMS) REGULATIONS 2008

I, MARY COUGHLAN, Minister for Enterprise, Trade and Employment, in exercise of the powers conferred on me by section 3 of the European Communi- ties Act 1972 (No. 27 of 1972) and for the purpose of giving effect to Council Regulation (EC) No. 816/2006 of the European Parliament and of the Council of 17 May 20061, hereby make the following regulations:

1. These Regulations may be cited as the European Communities (Compulsory Licensing of Patents relating to the Manufacture of Pharmaceut- ical Products for Export to Countries with Public Health Problems) Regu- lations 2008.

2. (1) In these Regulations—

“Controller” means the Controller of Patents, Designs and Trade Marks;

“Council Regulation” means Regulation (EC) No. 816/2006 of the European Parliament and of the Council of 17 May 20061;

“proceedings” means proceedings or an application under the Council Regu- lation and these Regulations.

(2) A word or expression that is used in these Regulations and is also used in the Council Regulation has the same meaning as in the Council Regulation.

(3) A reference to an Article in these Regulations is a reference to an Article of the Council Regulation.

(4) A reference to a Patent Rule in these Regulations is a reference to a Rule in the Patent Rules 1992 (S.I. No. 179 of 1992).

3. (1) The competent authority in the State for the purposes of the Council Regulation (including Article 14) shall be the Controller.

(2) The body referred to in Article 14(1) with the authority to review as provided therein shall be the Irish Medicines Board.

(3) The appropriate body within the meaning of Article 17 shall be the High Court. 1OJ No. L157, 9.6.2006, p.1.

Notice of the making of this Statutory Instrument was published in “Iris Oifigiúil” of 24th October, 2008.

[408] 3

4. (1) An application under Article 6 for a compulsory licence shall be made to the Controller in the form as set out in the Schedule.

(2) The application and supporting evidence shall be filed with the Controller in duplicate.

(3) The Controller shall afford the rights-holder a reasonable period to com- ment and provide relevant information pursuant to Article 7.

5. The Controller shall determine the application—

(a) on receipt of comments and relevant information by the rights- holder, or

(b) where the rights-holder has not provided comments and relevant information, after the termination of a reasonable period.

6. A request—

(a) where applicable, under Article 5(c), or

(b) under Article 16(1),

shall be made to the Controller and contain—

(i) the name and address of the person making the request,

(ii) information identifying the compulsory licence,

(iii) the name of the importing country, and

(iv) the facts and the grounds upon which the person making the request relies,

and shall be accompanied by evidence supporting the request.

7. The Controller may give such directions as he or she thinks fit with regard to proceedings, including—

(a) the requirement to reply to the Controller with comments and docu- ments within a period of time that the Controller considers reason- able, and

(b) the extension of any period of time for the filing of any document.

8. Where Article 17(2) applies, the Controller and the High Court shall have the power to rule that an appeal referred to therein shall have suspensory effect.

9. (1) Subject to these Regulations and the Council Regulation—

(a) sections 92 to 94 of the Patents Act 1992 (No. 1 of 1992), and

(b) Patent Rules 67, 69, 71 to 74, 76 and 91 to 97,

4 [408]

shall apply with any necessary modifications in relation to proceedings.

(2) Subject to Patent Rule 95, documents filed under these Regulations or the Council Regulation shall be in the Irish or English language.

[408] 5

SCHEDULE

Application for a Compulsory Licence of a Patent relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Prob- lems under Regulation (EC) No. 816/2006

1. Applicant:

Name

Address

2. Number of the Patent/Supplementary Protection Certificate:

Patent No(s).

SPC No(s).

3. Name and address of the Rights-Holder:

Please list the names and addresses of all rights-holders of the patent or Sup- plementary Protection Certificate:

Name

Address

4. Product identity:

Please state the non-proprietary name or other description by which the product for which a compulsory licence is requested is known:

5. Duration of licence sought:

Regulation 4.

6 [408]

6. Amount to be produced and importing countries:

(i) In respect of this application:

The importing country or countries The amount of the product which the applicant seeks to produce under the compulsory licence

Country 1

Country 2

Country 3

Country 4

(If the applicant is submitting applications for compulsory licences to auth- orities in other countries, please indicate below the countries in which appli- cations are being made together with details of the quantities to be produced and the names of the importing countries which are listed in those other applications).

(ii) Details of applications made in other countries:

Name of other country where an application for a compulsory licence has been made:

Duration of licence sought:

The importing country or countries The amount of the product which the applicant seeks to produce under the compulsory licence

Country 1

Country 2

Country 3

Country 4

7. Documents accompanying this application:

(a) Evidence of a specific request indicating the quantity of product required from one or more of the following:

(i) an authorised representative of the importing country or countries;

(ii) a non-governmental organisation acting with the formal authoris- ation of one or more of the importing countries;

(iii) a competent organ of the United Nations or an international health organisation acting with the formal authorisation of one or more of the importing countries.

[408] 7

(b) Evidence of prior negotiation with the rights-holder, including details of the terms, conditions and price proposed in respect of each pharm- aceutical product, pursuant to Article 9(1) of Regulation (EC) No. 816/2006 (unless not necessary by virtue of Article 9(2) of that Regulation).

8. Authorised Agent

(Please provide the name and address of the agent (if any) who is authorised to act as agent in all proceedings connected with this application for a compul- sory licence and in relation to any licence granted).

Name of Agent

Address of Agent

Telephone No.

Fax No.

E-mail

9. Address for Service (if different from that at No. 8)

Address for service

Telephone No.

Fax No.

E-mail

Signed by or on behalf of applicant:

Dated:

8 [408]

GIVEN under my Official Seal, 10 October 2008

MARY COUGHLAN Minister for Enterprise, Trade and Employment.

[408] 9

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation).

These regulations lay down the procedural requirements which apply to requests for compulsory licensing of patents relating to the manufacture of pharmaceut- ical products for export to countries with public health problems. The purpose of the regulations is to give full effect to Council Regulation (EC) No. 816/2006 regarding conditions for granting compulsory licences to companies intending to manufacture medicinal products for export to developing countries which do not have sufficient production capacity of their own and which have public health problems.

BAILE ÁTHA CLIATH ARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR

Le ceannach dı́reach ón OIFIG DHÍOLTA FOILSEACHÁN RIALTAIS,

TEACH SUN ALLIANCE, SRÁID THEACH LAIGHEAN, BAILE ÁTHA CLIATH 2, nó trı́d an bpost ó

FOILSEACHÁIN RIALTAIS, AN RANNÓG POST-TRÁCHTA, AONAD 20 PÁIRC MIONDÍOLA COIS LOCHA, CLÁR CHLAINNE MHUIRIS,

CONTAE MHAIGH EO, (Teil: 01 - 6476834/37 nó 1890 213434; Fax: 01 - 6476843 nó 094 - 9378964)

nó trı́ aon dı́oltóir leabhar.

——————

DUBLIN PUBLISHED BY THE STATIONERY OFFICE

To be purchased directly from the GOVERNMENT PUBLICATIONS SALE OFFICE

SUN ALLIANCE HOUSE, MOLESWORTH STREET, DUBLIN 2, or by mail order from

GOVERNMENT PUBLICATIONS, POSTAL TRADE SECTION, UNIT 20 LAKESIDE RETAIL PARK, CLAREMORRIS, CO. MAYO, (Tel: 01 - 6476834/37 or 1890 213434; Fax: 01 - 6476843 or 094 - 9378964)

or through any bookseller.

——————

\3.05

Wt. (B26424). 305. 10/08. Cahill. Gr. 30-15.

其他文本 世贸组织通知首页 (3 文本) 世贸组织通知首页 (3 文本) 法语 Règlement de 2008 sur les licences obligatoires pour des brevets des Communautés européennes visant la fabrication de produits pharmarceutiques pour l'exportation vers des pays avec des problèmes de santé publique (S.I. n° 408/2008) 西班牙语 Reglamento de 2008 sobre la concesión de licencias obligatorias sobre patentesde las Comunidades Europeas visando la fabricación de productos farmacéuticos para la exportación frente a los países con problemas de salud pública (S.I. N° 408/2008) 英语 European Communities (Compulsory Licensing of Patents Relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Problems) Regulations 2008 (S.I. No. 408/2008)
 European Communities (Compulsory Licensing of Patents Relating to the manufacture of pharmaceutical products for export to countries with public health problems) Regulations 2008

STATUTORY INSTRUMENTS

S.I. No. 408 of 2008

————————

EUROPEAN COMMUNITIES (COMPULSORY LICENSING OF PATENTS RELATING TO THE MANUFACTURE OF

PHARMACEUTICAL PRODUCTS FOR EXPORT TO COUNTRIES WITH PUBLIC HEALTH PROBLEMS) REGULATIONS 2008

(Prn. A8/1651)

2 [408]

S.I. No. 408 of 2008

EUROPEAN COMMUNITIES (COMPULSORY LICENSING OF PATENTS RELATING TO THE MANUFACTURE OF

PHARMACEUTICAL PRODUCTS FOR EXPORT TO COUNTRIES WITH PUBLIC HEALTH PROBLEMS) REGULATIONS 2008

I, MARY COUGHLAN, Minister for Enterprise, Trade and Employment, in exercise of the powers conferred on me by section 3 of the European Communi- ties Act 1972 (No. 27 of 1972) and for the purpose of giving effect to Council Regulation (EC) No. 816/2006 of the European Parliament and of the Council of 17 May 20061, hereby make the following regulations:

1. These Regulations may be cited as the European Communities (Compulsory Licensing of Patents relating to the Manufacture of Pharmaceut- ical Products for Export to Countries with Public Health Problems) Regu- lations 2008.

2. (1) In these Regulations—

“Controller” means the Controller of Patents, Designs and Trade Marks;

“Council Regulation” means Regulation (EC) No. 816/2006 of the European Parliament and of the Council of 17 May 20061;

“proceedings” means proceedings or an application under the Council Regu- lation and these Regulations.

(2) A word or expression that is used in these Regulations and is also used in the Council Regulation has the same meaning as in the Council Regulation.

(3) A reference to an Article in these Regulations is a reference to an Article of the Council Regulation.

(4) A reference to a Patent Rule in these Regulations is a reference to a Rule in the Patent Rules 1992 (S.I. No. 179 of 1992).

3. (1) The competent authority in the State for the purposes of the Council Regulation (including Article 14) shall be the Controller.

(2) The body referred to in Article 14(1) with the authority to review as provided therein shall be the Irish Medicines Board.

(3) The appropriate body within the meaning of Article 17 shall be the High Court. 1OJ No. L157, 9.6.2006, p.1.

Notice of the making of this Statutory Instrument was published in “Iris Oifigiúil” of 24th October, 2008.

[408] 3

4. (1) An application under Article 6 for a compulsory licence shall be made to the Controller in the form as set out in the Schedule.

(2) The application and supporting evidence shall be filed with the Controller in duplicate.

(3) The Controller shall afford the rights-holder a reasonable period to com- ment and provide relevant information pursuant to Article 7.

5. The Controller shall determine the application—

(a) on receipt of comments and relevant information by the rights- holder, or

(b) where the rights-holder has not provided comments and relevant information, after the termination of a reasonable period.

6. A request—

(a) where applicable, under Article 5(c), or

(b) under Article 16(1),

shall be made to the Controller and contain—

(i) the name and address of the person making the request,

(ii) information identifying the compulsory licence,

(iii) the name of the importing country, and

(iv) the facts and the grounds upon which the person making the request relies,

and shall be accompanied by evidence supporting the request.

7. The Controller may give such directions as he or she thinks fit with regard to proceedings, including—

(a) the requirement to reply to the Controller with comments and docu- ments within a period of time that the Controller considers reason- able, and

(b) the extension of any period of time for the filing of any document.

8. Where Article 17(2) applies, the Controller and the High Court shall have the power to rule that an appeal referred to therein shall have suspensory effect.

9. (1) Subject to these Regulations and the Council Regulation—

(a) sections 92 to 94 of the Patents Act 1992 (No. 1 of 1992), and

(b) Patent Rules 67, 69, 71 to 74, 76 and 91 to 97,

4 [408]

shall apply with any necessary modifications in relation to proceedings.

(2) Subject to Patent Rule 95, documents filed under these Regulations or the Council Regulation shall be in the Irish or English language.

[408] 5

SCHEDULE

Application for a Compulsory Licence of a Patent relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Prob- lems under Regulation (EC) No. 816/2006

1. Applicant:

Name

Address

2. Number of the Patent/Supplementary Protection Certificate:

Patent No(s).

SPC No(s).

3. Name and address of the Rights-Holder:

Please list the names and addresses of all rights-holders of the patent or Sup- plementary Protection Certificate:

Name

Address

4. Product identity:

Please state the non-proprietary name or other description by which the product for which a compulsory licence is requested is known:

5. Duration of licence sought:

Regulation 4.

6 [408]

6. Amount to be produced and importing countries:

(i) In respect of this application:

The importing country or countries The amount of the product which the applicant seeks to produce under the compulsory licence

Country 1

Country 2

Country 3

Country 4

(If the applicant is submitting applications for compulsory licences to auth- orities in other countries, please indicate below the countries in which appli- cations are being made together with details of the quantities to be produced and the names of the importing countries which are listed in those other applications).

(ii) Details of applications made in other countries:

Name of other country where an application for a compulsory licence has been made:

Duration of licence sought:

The importing country or countries The amount of the product which the applicant seeks to produce under the compulsory licence

Country 1

Country 2

Country 3

Country 4

7. Documents accompanying this application:

(a) Evidence of a specific request indicating the quantity of product required from one or more of the following:

(i) an authorised representative of the importing country or countries;

(ii) a non-governmental organisation acting with the formal authoris- ation of one or more of the importing countries;

(iii) a competent organ of the United Nations or an international health organisation acting with the formal authorisation of one or more of the importing countries.

[408] 7

(b) Evidence of prior negotiation with the rights-holder, including details of the terms, conditions and price proposed in respect of each pharm- aceutical product, pursuant to Article 9(1) of Regulation (EC) No. 816/2006 (unless not necessary by virtue of Article 9(2) of that Regulation).

8. Authorised Agent

(Please provide the name and address of the agent (if any) who is authorised to act as agent in all proceedings connected with this application for a compul- sory licence and in relation to any licence granted).

Name of Agent

Address of Agent

Telephone No.

Fax No.

E-mail

9. Address for Service (if different from that at No. 8)

Address for service

Telephone No.

Fax No.

E-mail

Signed by or on behalf of applicant:

Dated:

8 [408]

GIVEN under my Official Seal, 10 October 2008

MARY COUGHLAN Minister for Enterprise, Trade and Employment.

[408] 9

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation).

These regulations lay down the procedural requirements which apply to requests for compulsory licensing of patents relating to the manufacture of pharmaceut- ical products for export to countries with public health problems. The purpose of the regulations is to give full effect to Council Regulation (EC) No. 816/2006 regarding conditions for granting compulsory licences to companies intending to manufacture medicinal products for export to developing countries which do not have sufficient production capacity of their own and which have public health problems.

BAILE ÁTHA CLIATH ARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR

Le ceannach dı́reach ón OIFIG DHÍOLTA FOILSEACHÁN RIALTAIS,

TEACH SUN ALLIANCE, SRÁID THEACH LAIGHEAN, BAILE ÁTHA CLIATH 2, nó trı́d an bpost ó

FOILSEACHÁIN RIALTAIS, AN RANNÓG POST-TRÁCHTA, AONAD 20 PÁIRC MIONDÍOLA COIS LOCHA, CLÁR CHLAINNE MHUIRIS,

CONTAE MHAIGH EO, (Teil: 01 - 6476834/37 nó 1890 213434; Fax: 01 - 6476843 nó 094 - 9378964)

nó trı́ aon dı́oltóir leabhar.

——————

DUBLIN PUBLISHED BY THE STATIONERY OFFICE

To be purchased directly from the GOVERNMENT PUBLICATIONS SALE OFFICE

SUN ALLIANCE HOUSE, MOLESWORTH STREET, DUBLIN 2, or by mail order from

GOVERNMENT PUBLICATIONS, POSTAL TRADE SECTION, UNIT 20 LAKESIDE RETAIL PARK, CLAREMORRIS, CO. MAYO, (Tel: 01 - 6476834/37 or 1890 213434; Fax: 01 - 6476843 or 094 - 9378964)

or through any bookseller.

——————

\3.05

Wt. (B26424). 305. 10/08. Cahill. Gr. 30-15.


立法 实施 (3 文本) 实施 (3 文本)
无可用数据。

WIPO Lex编号 IE117